Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) shares rose 10.2% during trading on Thursday after an insider bought additional shares in the company. The stock traded as high as $8.18 and last traded at $8.1550. Approximately 575,175 shares traded hands during trading, a decline of 36% from the average daily volume of 892,004 shares. The stock had previously closed at $7.40.
Specifically, Director Brett Brodnax bought 35,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the purchase, the director owned 62,027 shares of the company’s stock, valued at $449,695.75. This trade represents a 129.50% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Wall Street Analyst Weigh In
LMRI has been the topic of a number of recent research reports. Barclays decreased their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday. Raymond James Financial upgraded shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective for the company in a research note on Monday, February 9th. Finally, Weiss Ratings initiated coverage on shares of Lumexa Imaging in a research report on Wednesday, May 13th. They set a “sell (e-)” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $16.00.
Lumexa Imaging Trading Up 10.5%
The firm has a fifty day moving average of $9.87.
Institutional Investors Weigh In On Lumexa Imaging
A number of large investors have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. acquired a new stake in Lumexa Imaging during the 4th quarter valued at $37,139,000. Janus Henderson Group PLC bought a new stake in shares of Lumexa Imaging during the fourth quarter worth $36,860,000. ArrowMark Colorado Holdings LLC bought a new stake in shares of Lumexa Imaging during the fourth quarter worth $27,750,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Lumexa Imaging in the fourth quarter valued at $27,750,000. Finally, Invesco Ltd. bought a new position in shares of Lumexa Imaging in the fourth quarter valued at about $26,562,000.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
Further Reading
- Five stocks we like better than Lumexa Imaging
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
